IDM CPD-Accredited Seminar: Reimagine Global Health: The Time is NOW Leveraging South African Cohorts to Develop Novel mRNA Vaccines Targeting Controller-Associated Mycobacterium tuberculosis-Specific T Cell Clones

IDM CPD-Accredited Seminar Program 2025

26 March 2025 | 13:00 - 14:00
Wolfson Pavilion Lecture Theatre, IDM Building

RSVP Here |  Add to Calendar

Speaker 

Munyaradzi’s research efforts are focused on the interface of tuberculosis (TB) immunology and clinical translation of promising TB vaccine concepts and TB biomarkers. He is involved in several projects that are characterising T cell responses induced by candidate TB vaccines, assessing promising TB biomarkers, and identifying antigens for candidate TB vaccines. Through his research, Munyaradzi hopes to gain insights that will inform vaccine design and biomarker development to ultimately reduce the disease burden cause by TB. He is part of the South African Tuberculosis Vaccine Initiative (SATVI).